Results 251 to 260 of about 339,556 (339)

An intracellular recombinant single‐chain variable antibody fragment as a new class of phosphodiesterase type 5 inhibitors

open access: yesBritish Journal of Pharmacology, EarlyView.
Background and Purpose Cyclic guanosine monophosphate (cGMP) is a ubiquitous second messenger involved in human (patho‐)physiology. Phosphodiesterase 5 (PDE5) is a major cGMP hydrolyzing enzyme in many cell types including vascular smooth muscle cells (VSMCs). Several highly selective PDE5 inhibitors are in clinical use. However, there are currently no
Kürsat Kirkgöz   +8 more
wiley   +1 more source

Structural transition of solvated H-Ras/GTP revealed by molecular dynamics simulation and local network entropy

open access: bronze, 2017
Shota Matsunaga   +8 more
openalex   +2 more sources

Cannabigerol reverses mechanical allodynia through α2A‐adrenergic modulation of thalamocortical signaling in chemotherapy‐induced neuropathy

open access: yesBritish Journal of Pharmacology, EarlyView.
Abstract Background and Purpose Chemotherapy‐induced peripheral neuropathy (CIPN) is a prevalent and treatment‐resistant side effect of platinum‐based chemotherapy, characterised by mechanical allodynia. Cannabigerol (CBG), a non‐psychoactive cannabinoid, has shown antinociceptive potential, but its site and mechanism of action remain unclear.
Quinn W. Wade   +7 more
wiley   +1 more source

The ribosome derives the energy to translocate and unwind mRNA from EF-G binding. [PDF]

open access: yesNat Commun
Amiri H   +7 more
europepmc   +1 more source

Signalling elements in higher plants: identification and molecular analysis of an auxin-binding-protein, GTP-binding regulatory proteins and calcium sensitive proteins

open access: green, 1989
Klaus Palme   +9 more
openalex   +1 more source

Covalent drug discovery: Progress against key targets, emerging strategies and lessons learnt

open access: yesBritish Journal of Pharmacology, EarlyView.
Abstract Covalent drug discovery is currently experiencing a boom in industrial and academic interest. To date, at least 75 covalent drugs have received regulatory approval, targeting both traditional target classes and more challenging proteins for which other approaches failed. In many cases, unique aspects of covalent targeting are essential for the
Charles P. Brown   +2 more
wiley   +1 more source

Ran modulates allosteric crosstalk between importin β surfaces. [PDF]

open access: yesNat Commun
Ko YH   +6 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy